Essbio S.A. Series C | Income Statement
Fiscal year is January-December. All values CLP Millions.
2013
2014
2015
2016
2017
Sales/Revenue
122,736
134,834
145,811
147,731
149,564
Cost of Goods Sold (COGS) incl. D&A
83,234
59,880
37,784
40,643
43,653
Gross Income
39,502
74,954
108,027
107,088
105,911
SG&A Expense
-
41,222
60,153
28,126
45,872
EBIT
39,502
33,732
47,874
47,463
46,370
Non Operating Income/Expense
4,057
10,921
7,226
8,826
1,565
Interest Expense
9,660
11,775
10,827
11,442
12,218
Pretax Income
26,716
12,724
31,373
28,273
34,013
Income Tax
5,853
56,521
5,833
4,584
7,457
Consolidated Net Income
20,863
69,244
25,540
23,689
26,557
Net Income
20,448
68,982
25,505
23,351
25,132
Net Income After Extraordinaries
20,448
68,982
25,505
22,152
24,173
Net Income Available to Common
20,448
68,982
25,505
24,549
26,090
EPS (Basic)
0.77
2.61
0.96
0.93
0.99
Basic Shares Outstanding
26,446
26,446
26,446
26,446
26,446
EPS (Diluted)
0.77
2.61
0.96
0.93
0.99
Diluted Shares Outstanding
26,446
26,446
26,446
26,446
26,446
EBITDA
58,389
57,194
68,795
68,856
71,285
Other Operating Expense
-
-
-
31,499
13,669
Non-Operating Interest Income
931
1,688
1,554
1,078
1,427
Minority Interest Expense
415
262
35
338
1,425
About Essbio
View Profile
